Patents/Inventors

Anna Ericsson

Shrewsbury, MAUS12 patents

13 Patents

US123782422025
Inhibiting CREB Binding Protein (CBP)
FORMA Therapeutics, Inc.
0 cites
US123515772025
Inhibiting Cyclic Amp-responsive Element-binding Protein (CREB)
FORMA Therapeutics, Inc.
0 cites
US122757152025
Pyridin-2(1h)-one Quinolinone Derivatives as Mutant-isocitrate Dehydrogenase Inhibitors
FORMA Therapeutics, Inc.
0 cites
US121280352024
Activating Pyruvate Kinase R
Novo Nordisk Health Care AG
0 cites
US121227782024
Activating Pyruvate Kinase R
Novo Nordisk Health Care AG
0 cites
US120714402024
Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators
Novo Nordisk Health Care AG
0 cites
US120534582024
Treating Sickle Cell Disease with a Pyruvate Kinase R Activating Compound
Novo Nordisk Health Care AG
0 cites
US120180302024
Pyrrolo and Pyrazolopyrimidines as Ubiquitin-specific Protease 7 Inhibitors
VALO HEALTH, Inc.
0 cites
US119806112024
Treating Sickle Cell Disease with a Pyruvate Kinase R Activating Compound
Novo Nordisk Health Care AG
0 cites
US118447872023
Activating Pyruvate Kinase R
NOVO NORDISK HEALTH CARE AG
0 cites
US118012432023
Bromodomain Inhibitors for Androgen Receptor-driven Cancers
Forma Therapeutics, Inc.
0 cites
US117878032023
Tetrahydro-imidazo Quinoline Compositions as CBP/P300 Inhibitors
Forma Therapeutics, Inc.
0 cites
US116492422023
Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators
FORMA THERAPEUTICS, Inc.
0 cites